Live feed
Filing
SC 13D
SC 13D0001213900-18-011785·Citius Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
CITIUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 17322U207
Event date: 2018-08-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 54.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-18-011785
- Form type
- SC 13D
- Filer
- Citius Pharmaceuticals, Inc.
- CIK
- CIK 1506251
- Filed
- Aug 27, 2018
- Reporting period
- Aug 13, 2018
- Description
- Schedule 13D beneficial ownership